WallStreetZenWallStreetZen

NASDAQ: RADX
Radiopharm Theranostics Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Radiopharm Theranostics earnings were -$24.0M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest RADX earnings report on Jun 30, 2025 announced Q2 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, RADX reported annual earnings of -$24.1M, with -21.2% growth. The next RADX earnings date is Sep 25, 2025.

RADX earnings history

Current Revenue
$2.4M
Current Earnings
-$24.1M
Current Profit Margin
-1,010.2%

RADX Return on Equity

Current Company
-100.7%
Current Industry
-9.6%
Current Market
31.1%
RADX's Return on Equity (-100.7%)... subscribe to Premium to read more.
High Return on Equity Performance

RADX undefined

Current Company
-46.3%
Current Industry
0%
RADX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RADX announces earnings.

RADX undefined

Current Company
-51.06%
Current Industry
7.7%
RADX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RADX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RADXN/A-$23.99MN/A-$24.33
GBIO-$67.79M-$72.42MN/A-$10.82
LVTX-$30.64M-$33.00MN/A-$1.23
OTLK-$43.25M-$43.44MN/A-$0.57
TELO-$16.15M-$16.14MN/A-$0.54
View Top Biotech Stocks

RADX earnings dates

Next earnings date
Sep 25, 2025

Radiopharm Theranostics Earnings Reports & History FAQ

What were Radiopharm Theranostics's earnings last quarter?

On RADX's earnings call on Invalid Date, Radiopharm Theranostics (NASDAQ: RADX) reported Q2 2025 earnings per share (EPS) of N/A, up N/A year over year. Total RADX earnings for the quarter were N/A. In the same quarter last year, Radiopharm Theranostics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Radiopharm Theranostics stock.

When does Radiopharm Theranostics report earnings?

The next RADX earnings call is Invalid Date. Add RADX to your watchlist to be reminded of Radiopharm Theranostics's next earnings date.

Is Radiopharm Theranostics profitable or losing money?

As of the last Radiopharm Theranostics earnings report, Radiopharm Theranostics is currently losing money. Radiopharm Theranostics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$24.15 million, a 21.23% decrease year over year.

What was RADX's earnings growth in the past year?

As of Radiopharm Theranostics's earnings date in Invalid Date, Radiopharm Theranostics's earnings has grown year over year. RADX earnings in the past year totalled -$23.99 million.

What are Radiopharm Theranostics's earnings expectations?

The current EPS estimate for Radiopharm Theranostics's earnings report in Invalid Date is $0.00.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.